Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...
Hosted on MSN45m
MHRA seeks input on new regulatory guidance for cancer vaccinesThe proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback